Acumen Pharmaceuticals Inc (ABOS) — Long-term Investment Intensity
Acumen Pharmaceuticals Inc (ABOS) has a Long-term Investment Intensity of 6.6% as of September 2025. Long-term investments of $9.44 Million represent 6.6% of total assets of $142.22 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Acumen Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Acumen Pharmaceuticals Inc Long-term Investment Intensity (2021–2024)
This chart shows how Acumen Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 6.6%, reflecting long-term investments of $9.44 Million against total assets of $142.22 Million USD. For the complete balance sheet picture, see Acumen Pharmaceuticals Inc balance sheet assets.
Annual Long-term Investment Intensity for Acumen Pharmaceuticals Inc (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Acumen Pharmaceuticals Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ABOS total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 25.1% | $59.97 Million | $238.99 Million | ▲ +4.9 pp |
| 2023 | 20.2% | $62.55 Million | $310.12 Million | ▲ +12.1 pp |
| 2022 | 8.1% | $15.84 Million | $196.59 Million | ▼ -5.7 pp |
| 2021 | 13.7% | $31.62 Million | $230.33 Million | — |